A recent study produced normative values for sleep data in healthy adults, which may help aid in future research.
Initiatives to debunk myths and promote healthful sleep practices may benefit public health.
Although both noninvasive ventilation and CPAP appear to exhibit similar long-term effectiveness in obesity hypoventilation syndrome, CPAP is thought to be the preferred first-line treatment modality because of its lower complexity and cost.
Objective short sleep duration is associated with daytime sleepiness, whereas obstructive sleep apnea is associated with obesity, dyslipidemia, and hypertension.
In obese patients with OSA, higher weight reduction was achieved in those who participated in a calorie restricted weight loss program and who received CPAP treatment.